Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of combining sunitinib with gemcitabine in pancreatic cancer and other solid tu…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the gamma-secretase inhibitor RO4929097 in combination with gemcitabine in patients with advanced pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint [Phase 2]
A Phase 2 trial evaluated the combination of panitumumab and gemcitabine for pancreatic cancer, using overall survival as the primary endpoi…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Dasatinib in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A phase 2 trial assessing dasatinib in metastatic pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for saracatinib in previously treated metastatic pancreatic cancer has completed with results posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab and gemcitabine with either cetuximab or erlotinib in advanced pancreatic cancer has completed and post…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer [Phase 1]
Phase 1 trial of RO4929097 before surgery in pancreatic cancer was terminated. The study was sponsored by the National Cancer Institute.
-
CLINICAL_TRIALS withdrawal · 2013-08-14Clinical Trial Update: Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 study of CPI-613 (devimistat) with or without gemcitabine for metastatic pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Micrometastasis in Gastrointestinal Cancer
Update on a clinical trial investigating micrometastasis in gastrointestinal cancers, focusing on pancreatic adenocarcinoma and colorectal c…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating radiotherapy with oxaliplatin and fluorouracil followed by gemcitabine in locally advanced, unresectable pancreatic…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 3]
Phase 3 clinical trial evaluating gemcitabine with or without bevacizumab for locally advanced or metastatic pancreatic cancer has completed…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma [Phase 2]
This Phase 2 randomized trial compared ARQ 197 (tivantinib) to gemcitabine in treatment-naïve patients with unresectable locally advanced or…
-
CLINICAL_TRIALS withdrawal · 2013-02-22Clinical Trial Update: Pancreatic Enzyme Suppletion in Pancreatic Cancer [Phase 4]
A Phase 4 trial evaluating pancreatic enzyme supplementation for pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma [Phase 4]
Phase 4 pharmacokinetic study evaluating adjuvant capecitabine after surgical resection of pancreatic adenocarcinoma; the trial status is co…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 clinical trial update reporting completion of a study evaluating UCN-01 with gemcitabine in patients with unresectable or metastatic…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration [NA]
A completed clinical trial comparing a new core histology needle used for EUS-guided fine-needle biopsy with conventional fine-needle aspira…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma [NA]
Clinical trial update on the use of Contrast-harmonic Endoscopic Ultrasound for diagnosing Pancreatic Adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection [NA]
This clinical trial evaluated the effect of preoperative chemotherapy on short-term outcomes after pancreatic resection. It focuses on local…
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer [EARLY_Phase 1]
Early-phase trial evaluating the effect on tumor perfusion of a gemcitabine and vismodegib chemotherapy given before surgery in resectable p…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial update for PTK787 (Vatalanib) in advanced metastatic pancreatic adenocarcinoma; the study status is listed as complet…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Second Line Chemotherapy for Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update evaluating second-line chemotherapy in patients with advanced pancreatic adenocarcinoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: A Study of CP-4126 in Patients With Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial of CP-4126 in patients with advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating temsirolimus in combination with gemcitabine for previously untreated metastatic pancreatic cancer; the study statu…
-
CLINICAL_TRIALS research · 2011-10-20Clinical Trial Update: Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
A multi-center clinical trial update evaluating the resectability of pancreatic head cancer using contrast-enhanced MDCT.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma [Phase 1]
This Phase 1 trial evaluating suicide gene therapy in combination with chemoradiotherapy for non-metastatic pancreatic adenocarcinoma was te…